Amniotic mesenchymal tissue cells inhibit dendritic cell differentiation of peripheral blood and amnion resident monocytes

Cell Transplantation

Volumn 18, Issue 8, 2009, Pages 899-914

  Magatti, Marta ^a   De Munari, Silvia ^a   Vertua, Elsa ^a   Nassauto, Claudia ^a   Albertini, Alberto ^b   Wengler, Georg S ^a   Parolini, Ornella ^a  

^a Fondazione Poliambulanza Istituto Ospedaliero   (Italy)

^b CNR   (Italy)

Author keywords

Amnion; Cell transplantation; Dendritic cell; Human placenta; Immunosuppression; Mesenchymal stromal cell; Monocyte

Indexed keywords

B7 ANTIGEN; CD83 ANTIGEN; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HLA DR ANTIGEN; RANTES; T6 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; AMNION; ANTIGEN PRESENTING CELL; ARTICLE; CELL CYCLE G0 PHASE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOMODULATION; MESENCHYME; MONOCYTE; MULTIPOTENT STEM CELL; NEWBORN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNTHESIS; T LYMPHOCYTE;

AMNION; BLOOD CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; DOWN-REGULATION; HUMANS; MESENCHYMAL STEM CELLS; MONOCYTES; PROTEIN BIOSYNTHESIS; T-LYMPHOCYTES;

EID: 72049107713     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368909X471314     Document Type: Article

References (62)

1. Aggarwal, S.; Pittenger, M. F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815-1822; 2005.
2. Agostini, C.; Calabrese, F.; Rea, F.; Facco, M.; Tosoni, A.; Loy, M.; Binotto, G.; Valente, M.; Trentin, L.; Semenzato, G. Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. Am. J. Pathol. 158:1703-1711; 2001.
3. Albert, M. L.; Jegathesan, M.; Darnell, R. B. Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat. Immunol. 2:1010-1017; 2001.
4. Bailo, M.; Soncini, M.; Vertua, E.; Signoroni, P. B.; Sanzone, S.; Lombardi, G.; Arienti, D.; Calamani, F.; Zatti, D.; Paul, P.; Albertini, A.; Zorzi, F.; Cavagnini, A.; Candotti, F.; Wengler, G. S.; Parolini, O. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation 78:1439-1448; 2004. (Pubitemid 39552929)
5. Beyth, S.; Borovsky, Z.; Mevorach, D.; Liebergall, M.; Gazit, Z.; Aslan, H.; Galun, E.; Rachmilewitz, J. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105:2214-2219; 2005. (Pubitemid 40731815)
6. Cargnoni, A.; Gibelli, L.; Bonassi Signoroni, P.; Nassuato, C.; Arienti, D.; Lombardi, G.; Albertini, A.; Wengler, G. S.; Parolini, O. Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis. Cell Transplant. 18(4):405-422; 2009.
7. Chen, L.; Zhang, W.; Yue, H.; Han, Q.; Chen, B.; Shi, M.; Li, J.; Li, B.; You, S.; Shi, Y.; Zhao, R. C. Effects of human mesenchymal stem cells on the differentiation of dendritic cells from CD34+ cells. Stem Cells Dev. 16:719-731; 2007.
8. Chomarat, P.; Banchereau, J.; Davoust, J.; Palucka, A. K. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat. Immunol. 1:510-514; 2000.
9. Colocho, G.; Graham, 3rd, W. P.; Greene, A. E.; Matheson, D. W.; Lynch, D. Human amniotic membrane as a physiologic wound dressing. Arch. Surg. 109:370-373; 1974.
10. Di Nicola, M.; Carlo-Stella, C.; Magni, M.; Milanesi, M.; Longoni, P. D.; Matteucci, P.; Grisanti, S.; Gianni, A. M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838-3843; 2002.
11. Djouad, F.; Charbonnier, L. M.; Bouffi, C.; Louis-Plence, P.; Bony, C.; Apparailly, F.; Cantos, C.; Jorgensen, C.; Noel, D. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6- dependent mechanism. Stem Cells 25:2025-2032; 2007. (Pubitemid 47258180)
12. Dua, H. S.; Gomes, J. A.; King, A. J.; Maharajan, V. S. The amniotic membrane in ophthalmology. Surv. Ophthalmol. 49:51-77; 2004.
13. English, K.; Barry, F. P.; Mahon, B. P. Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation. Immunol. Lett. 115:50-58; 2008.
14. Ennis, J.; Gotherstrom, C.; Le Blanc, K.; Davies, J. E. In vitro immunologic properties of human umbilical cord perivascular cells. Cytotherapy 10:174-181; 2008.
15. Fahmy, N. M.; Yamani, M. H.; Starling, R. C.; Ratliff, N. B.; Young, J. B.; McCarthy, P. M.; Feng, J.; Novick, A. C.; Fairchild, R. L. Chemokine and receptor-gene expression during early and late acute rejection episodes in human cardiac allografts. Transplantation 75:2044-2047; 2003.
16. Fang, L.; Lange, C.; Engel, M.; Zander, A. R.; Fehse, B. Sensitive balance of suppressing and activating effects of mesenchymal stem cells on T-cell proliferation. Transplantation 82:1370-1373; 2006. (Pubitemid 44832920)
17. Gomes, J. A.; Romano, A.; Santos, M. S.; Dua, H. S. Amniotic membrane use in ophthalmology. Curr. Opin. Ophthalmol. 16:233-240; 2005.
18. Gordon, S. Alternative activation of macrophages. Nat. Rev. Immunol. 3:23-35; 2003.
19. Gruss, J. S.; Jirsch, D. W. Human amniotic membrane: A versatile wound dressing. Can. Med. Assoc. J. 118:1237-1246; 1978.
20. Gur-Wahnon, D.; Borovsky, Z.; Beyth, S.; Liebergall, M.; Rachmilewitz, J. Contact-dependent induction of regulatory antigen-presenting cells by human mesenchymal stem cells is mediated via STAT3 signaling. Exp. Hematol. 35:426-433; 2007.
21. Hancock, W. W.; Lu, B.; Gao, W.; Csizmadia, V.; Faia, K.; King, J. A.; Smiley, S. T.; Ling, M.; Gerard, N. P.; Gerard, C. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J. Exp. Med. 192:1515-1520; 2000.
22. Hill, J. A.; Polgar, K.; Anderson, D. J. T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA 273:1933-1936; 1995.
23. Jiang, X. X.; Zhang, Y.; Liu, B.; Zhang, S. X.; Wu, Y.; Yu, X. D.; Mao, N. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105:4120-4126; 2005. (Pubitemid 40656164)
24. Jin Yu, S.; Soncini, M.; Kaneko, Y.; Hess, D.; Parolini, O.; Borlongan, C. Amnion: A potent graft source for cell therapy in stroke. Cell Transplant. 18(2):111-118; 2009.
25. Kesting, M. R.; Wolff, K. D.; Hohlweg-Majert, B.; Steinstraesser, L. The role of allogenic amniotic membrane in burn treatment. J. Burn Care Res. 29:907-916; 2008.
26. Klyushnenkova, E.; Mosca, J. D.; Zernetkina, V.; Majumdar, M. K.; Beggs, K. J.; Simonetti, D. W.; Deans, R. J.; McIntosh, K. R. T cell responses to allogeneic human mesenchymal stem cells: Immunogenicity, tolerance, and suppression. J. Biomed. Sci. 12:47-57; 2005.
27. Krampera, M.; Cosmi, L.; Angeli, R.; Pasini, A.; Liotta, F.; Andreini, A.; Santarlasci, V.; Mazzinghi, B.; Pizzolo, G.; Vinante, F.; Romagnani, P.; Maggi, E.; Romagnani, S.; Annunziato, F. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24:386-398; 2006. (Pubitemid 44464808)
28. Langenkamp, A.; Messi, M.; Lanzavecchia, A.; Sallusto, F. Kinetics of dendritic cell activation: Impact on priming of TH1, TH2 and nonpolarized T cells. Nat. Immunol. 1:311-316; 2000.
29. Le Blanc, K.; Rasmusson, I.; Sundberg, B.; Gotherstrom, C.; Hassan, M.; Uzunel, M.; Ringden, O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439-1441; 2004. (Pubitemid 38586721)
30. Le Blanc, K.; Tammik, L.; Sundberg, B.; Haynesworth, S. E.; Ringden, O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand. J. Immunol. 57:11-20; 2003.
31. Li, Y. P.; Paczesny, S.; Lauret, E.; Poirault, S.; Bordigoni, P.; Mekhloufi, F.; Hequet, O.; Bertrand, Y.; Ou-Yang, J. P.; Stoltz, J. F.; Miossec, P.; Eljaafari, A. Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway. J. Immunol. 180:1598-1608; 2008.
32. Lutz, M. B.; Schuler, G. Immature, semi-mature and fully mature dendritic cells: Which signals induce tolerance or immunity? Trends Immunol. 23:445-449; 2002.
33. Magatti, M.; De Munari, S.; Vertua, E.; Gibelli, L.; Wengler, G. S.; Parolini, O. Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities. Stem Cells 26:182-192; 2008.
34. Marcus, A. J.; Coyne, T. M.; Black, I. B.; Woodbury, D. Fate of amnion-derived stem cells transplanted to the fetal rat brain: Migration, survival and differentiation. J. Cell. Mol. Med. 12:1256-1264; 2008.
35. McIntosh, K.; Zvonic, S.; Garrett, S.; Mitchell, J. B.; Floyd, Z. E.; Hammill, L.; Kloster, A.; Di Halvorsen, Y.; Ting, J. P.; Storms, R. W.; Goh, B.; Kilroy, G.; Wu, X.; Gimble, J. M. The immunogenicity of human adipose-derived cells: Temporal changes in vitro. Stem Cells 24:1246-1253; 2006.
36. Meisel, R.; Zibert, A.; Laryea, M.; Gobel, U.; Daubener, W.; Dilloo, D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103:4619-4621; 2004. (Pubitemid 38745993)
37. Mellor, A. L.; Munn, D. H. Immunology at the maternal-fetal interface: Lessons for T cell tolerance and suppression. Annu. Rev. Immunol. 18:367-391; 2000.
38. Menetrier-Caux, C.; Montmain, G.; Dieu, M. C.; Bain, C.; Favrot, M. C.; Caux, C.; Blay, J. Y. Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: Role of interleukin-6 and macrophage colony-stimulating factor. Blood 92:4778-4791; 1998.
39. Munn, D. H.; Sharma, M. D.; Lee, J. R.; Jhaver, K. G.; Johnson, T. S.; Keskin, D. B.; Marshall, B.; Chandler, P.; Antonia, S. J.; Burgess, R.; Slingluff, Jr., C. L.; Mellor, A. L. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297:1867-1870; 2002.
40. Nauta, A. J.; Fibbe, W. E. Immunomodulatory properties of mesenchymal stromal cells. Blood 110:3499-3506; 2007.
41. Nauta, A. J.; Kruisselbrink, A. B.; Lurvink, E.; Willemze, R.; Fibbe, W. E. Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. J. Immunol. 177:2080-2087; 2006.
42. Parolini, O.; Alviano, F.; Bagnara, G. P.; Bilic, G.; Buhring, H. J.; Evangelista, M.; Hennerbichler, S.; Liu, B.; Magatti, M.; Mao, N.; Miki, T.; Marongiu, F.; Nakajima, H.; Nikaido, T.; Portmann-Lanz, C. B.; Sankar, V.; Soncini, M.; Stadler, G.; Surbek, D.; Takahashi, T. A.; Redl, H.; Sakuragawa, N.; Wolbank, S.; Zeisberger, S.; Zisch, A.; Strom, S. C. Concise review: Isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 26:300-311; 2008.
43. Potian, J. A.; Aviv, H.; Ponzio, N. M.; Harrison, J. S.; Rameshwar, P. Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J. Immunol. 171:3426-3434; 2003. (Pubitemid 37254543)
44. Puissant, B.; Barreau, C.; Bourin, P.; Clavel, C.; Corre, J.; Bousquet, C.; Taureau, C.; Cousin, B.; Abbal, M.; Laharrague, P.; Penicaud, L.; Casteilla, L.; Blancher, A. Immunomodulatory effect of human adipose tissue-derived adult stem cells: Comparison with bone marrow mesenchymal stem cells. Br. J. Haematol. 129:118-129; 2005.
45. Raghupathy, R. Th1-type immunity is incompatible with successful pregnancy. Immunol. Today 18:478-482; 1997. (Pubitemid 27441590)
46. Ramasamy, R.; Fazekasova, H.; Lam, E. W.; Soeiro, I.; Lombardi, G.; Dazzi, F. Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation 83:71-76; 2007. (Pubitemid 46104974)
47. Rasmusson, I. Immune modulation by mesenchymal stem cells. Exp. Cell Res. 312:2169-2179; 2006.
48. Ren, G.; Zhang, L.; Zhao, X.; Xu, G.; Zhang, Y.; Roberts, A. I.; Zhao, R. C.; Shi, Y. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2:141-150; 2008. (Pubitemid 351181031)
49. Ringden, O.; Uzunel, M.; Rasmusson, I.; Remberger, M.; Sundberg, B.; Lonnies, H.; Marschall, H. U.; Dlugosz, A.; Szakos, A.; Hassan, Z.; Omazic, B.; Aschan, J.; Barkholt, L.; Le Blanc, K. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81:1390-1397; 2006. (Pubitemid 43847148)
50. Sankar, V.; Muthusamy, R. Role of human amniotic epithelial cell transplantation in spinal cord injury repair research. Neuroscience 118:11-17; 2003. (Pubitemid 36369525)
51. Sato, K.; Ozaki, K.; Oh, I.; Meguro, A.; Hatanaka, K.; Nagai, T.; Muroi, K.; Ozawa, K. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 109:228-234; 2007. (Pubitemid 46053063)
52. Shortman, K.; Naik, S. H. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 7:19-30; 2007.
53. Spaggiari, G. M.; Capobianco, A.; Abdelrazik, H.; Becchetti, F.; Mingari, M. C.; Moretta, L. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: Role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 111:1327-1333; 2008. (Pubitemid 351213419)
54. Uccelli, A.; Pistoia, V.; Moretta, L. Mesenchymal stem cells: A new strategy for immunosuppression? Trends Immunol. 28:219-226; 2007.
55. Ueta, M.; Kweon, M. N.; Sano, Y.; Sotozono, C.; Yamada, J.; Koizumi, N.; Kiyono, H.; Kinoshita, S. Immunosuppressive properties of human amniotic membrane for mixed lymphocyte reaction. Clin. Exp. Immunol. 129:464-470; 2002.
56. Wang, M.; Yang, Y.; Yang, D.; Luo, F.; Liang, W.; Guo, S.; Xu, J. The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Immunology 126:220-232; 2009.
57. Ward, D. J.; Bennett, J. P. The long-term results of the use of human amnion in the treatment of leg ulcers. Br. J. Plast. Surg. 37:191-193; 1984.
58. Ward, D. J.; Bennett, J. P.; Burgos, H.; Fabre, J. The healing of chronic venous leg ulcers with prepared human amnion. Br. J. Plast. Surg. 42:463-467; 1989.
59. Wegmann, T. G.; Lin, H.; Guilbert, L.; Mosmann, T. R. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a TH2 phenomenon? Immunol. Today 14:353-356; 1993.
60. Wolbank, S.; Peterbauer, A.; Fahrner, M.; Hennerbichler, S.; van Griensven, M.; Stadler, G.; Redl, H.; Gabriel, C. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: A comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng. 13:1173-1183; 2007. (Pubitemid 46986718)
61. Zhang, B.; Liu, R.; Shi, D.; Liu, X.; Chen, Y.; Dou, X.; Zhu, X.; Lu, C.; Liang, W.; Liao, L.; Zenke, M.; Zhao, R. C. Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2 dependent regulatory dendritic cell population. Blood 113:46-57; 2009.
62. Zhang, W.; Ge, W.; Li, C.; You, S.; Liao, L.; Han, Q.; Deng, W.; Zhao, R. C. Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev. 13:263-271; 2004.